Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular features, markers, drug targets, and prospective targeted therapeutics in cardiac myxoma.

Current cancer drug targets - 1 Sept 2009

Barh Debmalya, Kumar Anil, Chatterjee Suvro, Liloglou Triantafillos

Abstract excerpt

Treatment of sporadic cardiac myxoma (CM) has always been a challenging task. Currently, surgical excision remains the only option; however, targeted drug discovery schemes are in progress in order to improve treatment strategies and efficacy. The molecular mechanisms behind CM pathogenesis are s...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor
Share to Cell Line

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Delivery Systems

Share to Drug Discovery

Share to Heart Neoplasms

Share to Models, Biological

Share to Signal Transduction

Source

Identifiers

PMID: 19754355
DOI: 10.2174/156800909789271549

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19754355-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular features, markers, drug targets, and prospective targeted therapeutics in cardiac myxoma.PMID 19754355Read ↗

Genetic aberrations and molecular biology of cardiac sarcomaSemantic proximity Read ↗

Resolving the heterogeneous tumour microenvironment in cardiac myxoma through single‐cell and spatial transcriptomicsSemantic proximity Read ↗

10× single-cell sequencing revealed cellular composition heterogeneity in cardiac myxoma with malignant glandular properties.Semantic proximity Read ↗

Frequent protein kinase A regulatory subunit A1 mutations but no GNAS mutations as potential driver in sporadic cardiac myxomas.Semantic proximity Read ↗

Recent insights in striated muscle laminopathies.Semantic proximity Read ↗

Treatment of Canine Myxomatous Mitral Valve Disease:Current and Future ApproachesSemantic proximity Read ↗

Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without myxomatous mitral valve diseaseSemantic proximity Read ↗

Case Report: Left atrial myxoma with confirmed Delta variant COVID-19 infection, “to treat or withhold”Semantic proximity Read ↗

Advances in the understanding of the pathogenesis, progression and diagnosis of myxomatous mitral valve disease in dogs.Semantic proximity Read ↗

Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies.Semantic proximity Read ↗

New molecular targets in canine hemangiosarcoma-Comparative review and future of the precision medicine.Semantic proximity Read ↗

Emerging pathogenic mechanisms in human myxomatous mitral valve: lessons from past and novel data.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.